Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universe Pharmaceuticals (UPC) Long-Term Deferred Tax (2020 - 2023)

Universe Pharmaceuticals (UPC) has disclosed Long-Term Deferred Tax for 4 consecutive years, with $599078.0 as the latest value for Q3 2023.

  • Quarterly Long-Term Deferred Tax fell 55.55% to $599078.0 in Q3 2023 from the year-ago period, while the trailing twelve-month figure was $599078.0 through Sep 2023, down 55.55% year-over-year, with the annual reading at $599078.0 for FY2023, 55.55% down from the prior year.
  • Long-Term Deferred Tax hit $599078.0 in Q3 2023 for Universe Pharmaceuticals, down from $1.3 million in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $1.3 million in Q3 2022 to a low of $186537.0 in Q3 2020.
  • Historically, Long-Term Deferred Tax has averaged $750821.0 across 4 years, with a median of $734537.5 in 2021.
  • Biggest five-year swings in Long-Term Deferred Tax: surged 366.39% in 2021 and later crashed 55.55% in 2023.
  • Year by year, Long-Term Deferred Tax stood at $186537.0 in 2020, then soared by 366.39% to $869997.0 in 2021, then soared by 54.91% to $1.3 million in 2022, then plummeted by 55.55% to $599078.0 in 2023.
  • Business Quant data shows Long-Term Deferred Tax for UPC at $599078.0 in Q3 2023, $1.3 million in Q3 2022, and $869997.0 in Q3 2021.